Flow Cytometric Evaluation of T Cell Activation Markers after Cardiopulmonary Bypass

Figure 2

Inhibition of CD25 ((a), (c)) and CD95 ((b), (d)) expression after treatment with Cyclosporin A (CsA; (a), (b)) or sirolimus (SRL; (c), (d)) and stimulation with different concentrations of ConA preoperatively (POD-0) and on postoperative days (POD)-3 and -7. Data are represented as mean ± S.E.M. Statistics: Mann-Whitney versus ConA 5 μg/mL; ^∗𝑃<0.05; ^∗∗𝑃<0.02; ^∗∗∗𝑃<0.01.

(a)

(b)

(c)

(d)